Novel

Xiaotan Yuan, Jiating Ma, Yiming Wu, Gang Zhao, Yujiong Wang

Abstract read

In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Frontiers in microbiology · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaotan YuanKey Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western China, Ningxia University, Yinchuan, China.

Jiating MaKey Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western China, Ningxia University, Yinchuan, China.

Yiming WuKey Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western China, Ningxia University, Yinchuan, China.

Gang ZhaoKey Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western China, Ningxia University, Yinchuan, China.

Yujiong WangKey Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western China, Ningxia University, Yinchuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mycoplasmopsis bovis, caused by Methods: In this study, 10 immunogenic Results: The results revealed that MbovP0592 was a secreted lipoprotein, while MbovP0659, MbovP0536, MbovP0393 and MbovP0585 were confirmed as membrane lipoproteins. Finally, the effects of MbovP0592, MbovP0659, MbovP0536, MbovP0393 and MbovP0585 on the inflammatory cytokines of host epithelial cells and macrophages were characterized by qRT-PCR. Conclusion: This study identified a secretory lipoprotein MbovP0592 along with four immunogenic membrane lipoproteins, all of which possess the ability to initiate inflammatory responses in host cells. These results provide potential candidates for developing subunit vaccines and study the pathogenic mechanism of

Indexed as

Bacterial ProteinsCattle DiseasesEpithelial CellsLipoproteinsMacrophagesMycoplasma bovisMycoplasma InfectionsAnimalsCattleCytokinesFemaleHost-Pathogen InteractionsInflammationMiceBacterial ProteinsCytokinesLipoproteinsimmunogenicityinflammatory responsemembrane lipoproteinsMycoplasma bovissecreted lipoproteins

Identifiers

PMID40552297

DOI10.3389/fimmu.2025.1580436

PMCPMC12183183

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.